The Advisory Committee on Immunization Practices concluded that the benefits of resuming Janssen COVID-19 vaccination among persons aged ≥18 years outweighed the risks and reaffirmed its interim recommendation under FDA's Emergency Use Authorization, which includes a new warning for rare clotting events among women aged 18-49 years.
Among 3,171 nonhospitalized adult COVID-19 patients, 69% had one or more outpatient visits 28-180 days after the diagnosis. Two thirds had a visit for a new primary diagnosis, and approximately one third had a new specialist visit. Symptoms potentially related to COVID-19 were common new visit diagnoses. Visits for these symptoms decreased after 60 days but for some patients continued through 120-180 days.
Twenty-two possible breakthrough SARS-CoV-2 infections occurred among fully vaccinated persons ≥14 days after their second dose of COVID-19 vaccine. Two thirds of persons were asymptomatic. A minority of persons with breakthrough infection experienced mild to moderate COVID-19-like symptoms; two COVID-19-related hospitalizations and one death occurred. No facility-associated secondary transmission was identified.
In a COVID-19 outbreak at a Kentucky skilled nursing facility involving a newly introduced variant to the region, unvaccinated residents and health care personnel (HCP) had 3.0 and 4.1 times the risk of infection as did vaccinated residents and HCP. Vaccine was 86.5% protective against symptomatic illness among residents and 87.1% protective among HCP.
Based on laboratory scenarios, COVID-19 exposures were reduced by 23% to 57% in single-aisle and twin-aisle aircraft when the middle seat was kept vacant, compared with full aircraft occupancy.
This report describes changes in the number of emergency department visits during December 2020-January 2021 compared with the same months the year before.
Within each U.S. Census region, the proportion of hospitalized patients with COVID-19 was highest for Hispanic or Latino patients. Racial and ethnic disparities were largest during May-July 2020 and became less pronounced as the pandemic spread throughout the country; however, disparities remained in December 2020 in all regions.
Investigators analyzed data on in-school COVID-19 testing among 594 students who were exposed to 33 index patients at 13 elementary schools. Compared with non-Hispanic White students, participation in the program was higher among students identifying as Hispanic/Latino White or members of another racial minority group.
Based on laboratory scenarios, COVID-19 exposures were reduced by 23% to 57% in single-aisle and twin-aisle aircraft when the middle seat was kept vacant, compared with full aircraft occupancy.
Within each U.S. Census region, the proportion of hospitalized patients with COVID-19 was highest for Hispanic or Latino patients. Racial and ethnic disparities were largest during May-July 2020 and became less pronounced as the pandemic spread throughout the country; however, disparities remained in December 2020 in all regions.
Data from 13 states indicate that compared with White persons, Hispanic and American Indian or Alaska Native persons experienced 1.7 times the rate, and Black persons experienced 1.4 times the rate of emergency department care visits for COVID-19 during October-December 2020.
Forty-six cases of COVID-19 were linked to an indoor bar opening event that occurred during February 2021 in a rural Illinois county. Event patrons were linked to secondary cases among household, long-term care facility, and school contacts.
Among 378,048 death certificates from 2020 listing COVID-19 as a cause of death, 5.5% listed COVID-19 without codes for any other conditions. Among 357,133 death certificates with at least one other diagnosis, 97% had a co-occurring diagnosis of a plausible chain-of-event condition, a significant contributing condition, or both.
The age-adjusted death rate increased by 15.9% in 2020. Overall death rates were highest among Black and American Indian or Alaska Native people. COVID-19 was the third leading cause of death, and the COVID-19 death rate was highest among Hispanics.
This report describes an outbreak of COVID-19 in a correctional facility after incarcerated persons were exposed by a visiting dental health care provider.
mRNA COVID-19 vaccine effectiveness against SARS-CoV-2 infection was 90% for full immunization (≥14 days after second dose) and 80% for partial immunization (≥14 days after first dose but before second dose) in real-world conditions.
From August 2020-February 2021, adults with recent symptoms of an anxiety or depressive disorder increased from 36% to 42%. Increases were largest among adults 18-29 years and those with less than a high school education.
This report describes a population-based analysis of COVID-19 incidence among counties with relatively large percentages of persons belonging to five racial and ethnic minority groups.
This report describes a program that increased the number of persons with HIV infections who initiated antiretroviral therapy before and during the COVID-19 pandemic.
In 22 participating K-12 schools implementing multiple COVID-19 mitigation strategies, school-based SARS-CoV-2 secondary transmission was detected in two of 102 tested close contacts of 37 persons with COVID-19.
COVID-19 school-related cases among Florida students correlated with community incidence in the counties observed, and was highest in smaller counties, districts without mask requirements, and those that reopened earliest.
In a high community transmission setting in Salt Lake County, Utah, low school-associated transmission was observed. Mask adherence was high, but physical distancing of >=6 feet was not possible so classroom seats were a median of 3 ft apart.